骨科老年共管模式对住院老年髋部骨折患者处方模式的影响
一项23个月回顾性观察研究纳入872例65岁以上股骨近端骨折患者,比较实施骨科老年共管单元前后的住院处方模式。共管模式显著增加通便药、造血治疗和二级骨折预防药物处方,减少肌注氟哌啶醇使用,未调整院内死亡率从7.7%降至2.9%(p=0.005)。
要点
- 共管模式显著提高钙剂、维生素D和唑来膦酸等二级预防处方。
- 共管模式显著增加乳果糖、比沙可啶等通便药及叶酸、羧基麦芽糖铁处方。
- 肌注氟哌啶醇使用显著减少,未调整院内死亡率显著下降。
核心结论
- 骨科老年共管模式优化了股骨近端骨折老年患者多个关键治疗领域的住院处方管理并改善患者生存。
研究设计与样本
- 23个月回顾性观察研究,连续纳入872例年龄≥65岁的股骨近端骨折住院患者,比较实施骨科老年共管单元前后队列的处方模式。
主要发现
- 乳果糖处方从8.1%增至74.5%(p<0.001),口服比沙可啶从2.7%增至48.9%(p<0.001)。
- 叶酸处方从6.8%增至22.0%(p<0.001),羧基麦芽糖铁从1.4%增至20.6%(p<0.001)。
- 钙剂处方从2.7%增至51.5%(p<0.001),维生素D从2.5%增至56.7%(p<0.001),唑来膦酸从1.4%增至12.7%(p<0.001)。
- 肌注氟哌啶醇使用从21.7%降至10.9%(p<0.001),口服对乙酰氨基酚使用增加,阿片类药物处方保持稳定。
- 未调整院内死亡率从7.7%降至2.9%(p=0.005)。
临床怎么用
- 对住院老年股骨近端骨折患者实施骨科老年共管模式,可主动规范化通便、造血支持和二级骨折预防等处方。
- 共管模式有助于减少肌注氟哌啶醇等 delirium 相关用药,并可能改善院内生存。
局限性
- 研究为回顾性观察设计,仅描述实施前后队列比较,未调整混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Orthogeriatric co-management aims to optimize care for high-risk hip fracture patients. Implementation significantly increased secondary prevention (osteoporosis/anemia) and reduced intramuscular haloperidol. With a 63% relative reduction in mortality (8.6% to 3.2%), this model proves essential for enhancing safety and survival in complex older populations. PURPOSE: Proximal femoral fractures (PFF) impose a substantial burden on older adults and healthcare systems. Orthogeriatric co-management aims to optimize care for this high-risk population, yet its influence on in-hospital prescribing is poorly characterized. This study examines how implementing an orthogeriatric unit affects medication patterns in hospitalized older adults with PFF. METHODS: A 23-month retrospective, observational study included consecutively admitted PFF patients aged ≥65 years. Clinical and pharmacological data (demographics, chronic medications, length of stay, surgical timing) were extracted from electronic and pharmacy records. In-hospital prescribing was assessed across key domains: analgesia, anaemia, delirium, antimicrobial stewardship, bowel regulation, and osteoporosis. Pre- and post-implementation cohorts were compared using descriptive statistics, chi-squared, and t tests (p < 0.05). RESULTS: A total of 872 patients were included in the study. Implementation of the orthogeriatric unit was associated with significant increases in the prescription of laxatives (lactulose: 8.1% vs 74.5% p < 0.001; oral bisacodyl: 2.7% vs 48.9% p < 0.001), haematopoietic therapies (folic acid: 6.8% vs 22.0% p < 0.001; ferric carboxymaltose: 1.4% vs 20.6% p < 0.001), and secondary fracture prevention treatments (calcium: 2.7% vs 51.5% p < 0.001; vitamin D: 2.5% vs 56.7% p < 0.001; zoledronic acid: 1.4% vs 12.7% p < 0.001). Intramuscular haloperidol use significantly decreased (21.7% vs 10.9% p < 0.001). Oral paracetamol use increased, while opioid prescribing remained stable. Unadjusted intra-hospital mortality declined significantly (7.7% vs 2.9%, p = 0.005). CONCLUSION: The orthogeriatric approach successfully streamlined both management across key therapeutic domains and patient survival. This study quantifies the positive impact of co-management, supporting evidence for the implementation of safer, proactive therapeutic protocols in hip fracture care.
引用
- Mendes-Piteira S, Reis FF, Ferreira HA, et al. Impact of orthogeriatric care: prescription patterns in hospitalized older adults. Osteoporos Int. 2026. PMID: 42806170. doi:10.1007/s00198-026-08244-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。